Cargando…
Replenishing NAD(+) content reduces aspects of striated muscle disease in a dog model of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in DMD gene and loss of the protein dystrophin, which ultimately leads to myofiber membrane fragility and necrosis, with eventual muscle atrophy and contractures. Affected boys typically die in their second or third decade...
Autores principales: | Cardoso, Déborah, Barthélémy, Inès, Blot, Stéphane, Muchir, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694913/ https://www.ncbi.nlm.nih.gov/pubmed/38044436 http://dx.doi.org/10.1186/s13395-023-00328-w |
Ejemplares similares
-
Need for NAD(+): Focus on Striated Muscle Laminopathies
por: Cardoso, Déborah, et al.
Publicado: (2020) -
Effects of an Immunosuppressive Treatment in the GRMD Dog Model of Duchenne Muscular Dystrophy
por: Barthélémy, Inès, et al.
Publicado: (2012) -
Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
por: Barthélémy, Inès, et al.
Publicado: (2014) -
Spatial and Temporal Non-Uniform Changes in Left Ventricular Myocardial Strain in Dogs with Duchenne Muscular Dystrophy
por: Ghaleh, Bijan, et al.
Publicado: (2023) -
Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2020)